INHIBITION OF METASTATIC HEPATOCARCINOMA BY COMBINED CHEMOTHERAPY WITH SILENCING VEGF/VEGFR2 GENES THROUGH A GALNAC-MODIFIED INTEGRATED THERAPEUTIC SYSTEM

Inhibition of Metastatic Hepatocarcinoma by Combined Chemotherapy with Silencing VEGF/VEGFR2 Genes through a GalNAc-Modified Integrated Therapeutic System

Custom Shaped Wood Sign Hepatocellular carcinoma (HCC) is a highly malignant tumor related to high mortality and is still lacking a satisfactory cure.Tumor metastasis is currently a major challenge of cancer treatment, which is highly related to angiogenesis.The vascular endothelial growth factor (VEGF)/VEGFR signaling pathway is thus becoming an a

read more